Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2012 066 411.8 |
| 96 | EP file number | EAKZ | 12 78 5097.2 |
| 86 | WO file number | WAKZ | PCT/US2012/038214 |
| 97 | EP publication number | EPN | 2710007 |
| 87 | WO publication number | WPN | 2012158843 |
| 54 | Designation/title | TI | KINASE-INHIBITOREN |
| 51 | IPC main class | ICM
(ICMV) | C07D 487/04 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | C07D 403/04 (2006.01), C07D 401/04 (2006.01), A61K 31/519 (2006.01), A61P 29/00 (2006.01), A61P 35/00 (2006.01) |
| 22 | DE application date | DAT | May 16, 2012 |
| 96 | EP application date | EAT | May 16, 2012 |
| 86 | WO application date | WAT | May 16, 2012 |
| 43 | Date of first publication | OT | Nov 22, 2012 |
| Date of publication of grant | PET | Dec 11, 2019 |
| 71/73 | Applicant/owner | INH | Principia Biopharma Inc., South San Francisco, Calif., US; The Regents of The University of California, Oakland, Calif., US |
| 72 | Inventor | IN | TAUNTON, John William, Jr., San Francisco California 94110, US; BRAMELD, Kenneth Albert, Menlo Park California 94027, US; GOLDSTEIN, David Michael, Redwood City California 94061, US; MCFARLAND, Jesse, Oakland California 94606, US; KRISHNAN, Shyam, San Francisco California 94131, US; CHOY, Jonathan, Lafayette California 94549, US |
| 74 | Representative | VTR | Hernandez, Yorck, Dipl.-Ing., 82031 Grünwald, DE |
| Address for service | | HERNANDEZ IP, 82031 Grünwald, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201161487233 P
May 17, 2011
|
| Due date | FT
FG | May 31, 2026
Annual fee for the 15th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document: EP000002710007
Searchable text:
EP000002710007
Original document:
EP000002710007B1
Searchable text:
EP000002710007B1
Original document:
WO002012158843
Searchable text:
WO002012158843 |
| 43 | Date of first publication | EVT | Nov 22, 2012 |
| Date of the first transfer into DPMAregister | EREGT | May 8, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 7, 2025
(Show all update days)(Hide all update days)- Jun 7, 2025
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 11.12.2019: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 11.12.2019: deleted
- May 8, 2014
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)| INID | Criterion | Field | Content
Close details
|
|---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 8, 2020 |
| Issue number | HN | 20 |
| Year | PJ | 2020 |
| Publication date | VT | May 14, 2020 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
| 71/73 | Applicant/owner | INH | Principia Biopharma Inc., South San Francisco, Calif., US; The Regents of The University of California, Oakland, Calif., US |
| 71/73 | Previous applicant/owner | INHF | Principia Biopharma, Inc., Menlo Park, CA, US, The Regents of The University of California, Oakland, Calif., US |
